Related Experiment Video
Updated: Jun 12, 2026
08:49
External Cephalic Version: Is it an Effective and Safe Procedure?
Published on: June 6, 2020
Recurrence of breech presentation in consecutive pregnancies
J B Ford1, C L Roberts, N Nassar
1Kolling Institute of Medical Research, University of Sydney, Australia. Jane.Ford@sydney.edu.au
Summary
Women with a history of breech presentation face a significantly increased recurrence risk in subsequent pregnancies. Close monitoring during late pregnancy is recommended for those with prior breech deliveries.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Epidemiology
Background:
- Breech presentation at term is a common obstetric complication.
- Understanding recurrence risk is crucial for effective management and counseling.
Purpose of the Study:
- To investigate the recurrence risk of breech presentation at term.
- To identify maternal and infant risk factors associated with breech recurrence.
Main Methods:
- A retrospective cohort study was conducted using data from New South Wales, Australia (1994-2002).
- Included women with their first two (n=113,854) and first three (n=21,690) consecutive singleton term pregnancies.
- Descriptive statistics, relative risks, and adjusted relative risks (logistic regression, Poisson analyses) were calculated.
Main Results:
- The recurrence rate of breech presentation in a second consecutive pregnancy was 9.9% (RR 3.2), and in a third was 27.5% (RR 13.9).
- Factors associated with recurrence included placenta previa, maternal diabetes, advanced maternal age (>35), birth defects, and female infant sex.
- Adjusted relative risks (aRR) ranged from 1.2 to 2.5 for identified risk factors.
Conclusions:
- A history of breech presentation significantly increases the risk of recurrence in subsequent pregnancies.
- Women with prior breech deliveries require close monitoring in the latter stages of pregnancy.
- Identification of risk factors can aid in targeted surveillance and management strategies.
Related Concept Videos
01:19Mitral Valve Prolapse III: Nursing Management
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
01:28Development of the Oral Microbiota
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
01:49Probability Laws
Overview
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:21Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...